249420 일동제약
기본 정보
- 섹터: KOSPI:제약
- 시가총액: 5,346억원 (2026-06-30 기준)
- 첫 등장: 2026-06-29 (누적 1일)
- 태그: 매크로/바이오헬스 · 제약 · 의약품 · 신약개발 · 비타민 · 소화기치료제
- 네이버 금융: 🔗
기업개요
- 동사는 2016년 설립된 종합 제약기업으로 의약품, 원료, 건강보조 및 특수영양식품 제조·판매 사업을 하고 있음.
- 활성비타민 아로나민, 항생제 후루마린 등 주요 의약품을 생산하며, 매출 566,934백만원 중 36,591백만원을 연구개발에 투자함.
- 위식도 역류, 대사성·호흡기 질환 치료제 개발과 코로나치료제 ID32124, 위산 질환 치료제 ID120040002 신약 개발에 집중하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | 14,600 | 13,700 | 🔵 -6.16% | +0.21%p | ×1.8 | 🟢 외인 | +1.9억 | +2.5 | -0.7 | +0.1 | +0.0 | -1.9 | +0.0 |
| 2026-07-13 | 15,300 | 14,600 | 🔵 -4.58% | +0.58%p | ×0.8 | 🔻 개인 | -2.7억 | -3.0 | +0.2 | -0.5 | +0.0 | +3.2 | +0.0 |
| 2026-07-10 | 14,780 | 15,300 | 🔴 +3.52% | -0.67%p | ×0.8 | 🟢 외인 | +7.5억 | +9.5 | -1.9 | -0.9 | -0.1 | -6.2 | -0.5 |
| 2026-07-09 | 14,520 | 14,780 | 🔴 +1.79% | -0.48%p | ×1.1 | 🟢 외인 | +4.6억 | +4.3 | +0.2 | +0.1 | +0.0 | -4.8 | +0.0 |
| 2026-07-08 | 15,950 | 14,520 | 🔵 -8.97% | -4.21%p | ×1.0 | 🟢 외인 | +1.6억 | +1.6 | +0.0 | -0.3 | +0.0 | -1.1 | -0.1 |
| 2026-07-07 | 16,510 | 15,950 | 🔵 -3.39% | -0.60%p | ×0.7 | 🔻 개인 | -2.8억 | -2.8 | +0.0 | -0.5 | -0.1 | +3.3 | -0.0 |
| 2026-07-06 | 16,390 | 16,510 | 🔴 +0.73% | -1.10%p | ×1.1 | 🟣 투신 | +4.9억 | -4.7 | +0.0 | +0.2 | +9.6 | -5.0 | -0.1 |
| 2026-07-03 | 16,230 | 16,390 | 🔴 +0.55% | -0.31%p | ×0.8 | 🟢 외인 | +2.7억 | +2.7 | +0.0 | +0.2 | -0.0 | -2.8 | -0.0 |
| 2026-07-02 | 16,850 | 16,230 | 🔵 -3.68% | -0.42%p | ×0.7 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.2 | +0.0 | -0.6 | -0.1 |
| 2026-07-01 | 16,800 | 16,850 | 🔴 +0.30% | +0.06%p | ×0.7 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | +0.3 | +0.0 | -1.6 | +0.3 |
| 2026-06-30 | 17,630 | 16,800 | 🔵 -4.71% | -0.57%p | ×1.0 | 🔻 개인 | -3.1억 | -3.1 | +0.0 | -0.5 | +0.0 | +3.6 | +0.0 |
| 2026-06-29 | 15,910 | 17,630 | 🔴 +10.81% | -0.94%p | ×1.5 | 🟢 외인 | +15.8억 | +17.0 | -1.2 | +1.8 | +0.0 | -17.6 | +0.1 |
| 2026-06-26 | 16,950 | 15,910 | 🔵 -6.14% | -0.77%p | ×1.1 | 🟢 외인 | +8.6억 | +8.6 | +0.0 | +0.3 | +0.0 | -8.6 | -0.3 |
| 2026-06-25 | 17,460 | 16,950 | 🔵 -2.92% | +0.12%p | ×0.6 | 🔻 개인 | -1.0억 | -1.4 | +0.2 | -0.2 | +0.2 | +1.2 | +0.0 |
| 2026-06-24 | 16,050 | 17,460 | 🔴 +8.79% | -0.74%p | ×1.2 | 🟢 외인 | +14.0억 | +12.1 | +1.9 | +0.8 | -0.0 | -15.2 | +0.4 |
| 2026-06-23 | 17,620 | 16,050 | 🔵 -8.91% | -2.78%p | ×1.0 | 🟢 외인 | +10.2억 | +9.8 | +0.4 | -0.0 | -9.4 | -0.8 | |
| 2026-06-22 | 18,210 | 17,620 | 🔵 -3.24% | -0.77%p | ×0.8 | 🟢 외인 | +3.9억 | +3.9 | +0.0 | -0.0 | -3.9 | +0.1 | |
| 2026-06-19 | 19,130 | 18,210 | 🔵 -4.81% | -0.52%p | ×0.9 | 🟢 외인 | +3.3억 | +3.2 | +0.1 | -0.1 | -3.0 | -0.2 | |
| 2026-06-18 | 19,850 | 19,130 | 🔵 -3.63% | +0.55%p | ×0.5 | 🔻 개인 | -6.2억 | -6.2 | +0.0 | +0.3 | +6.1 | -0.2 | |
| 2026-06-17 | 19,500 | 19,850 | 🔴 +1.79% | +0.05%p | ×0.7 | 🟢 외인 | +4.4억 | +4.4 | +0.0 | +0.4 | -4.7 | -0.1 | |
| 2026-06-16 | 19,570 | 19,500 | 🔵 -0.36% | -0.46%p | ×0.7 | 🟢 외인 | +5.2억 | +5.5 | -0.3 | -0.1 | -1.3 | -3.8 | |
| 2026-06-15 | 19,320 | 19,570 | 🔴 +1.29% | +0.36%p | ×0.4 | ⚫ 그외 | -5.5억 | -5.5 | +0.0 | +0.1 | -0.2 | +5.5 | |
| 2026-06-12 | 18,780 | 19,320 | 🔴 +2.88% | +0.27%p | ×0.7 | 🟢 외인 | +7.3억 | +7.3 | +0.0 | +0.1 | -4.5 | -2.9 | |
| 2026-06-11 | 18,350 | 18,780 | 🔴 +2.34% | +1.14%p | ×0.5 | 🟢 외인 | +2.5억 | +2.5 | +0.0 | +0.0 | -3.2 | +0.7 | |
| 2026-06-10 | 18,830 | 18,350 | 🔵 -2.55% | -1.97%p | ×0.5 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | -0.0 | -0.7 | -0.1 | |
| 2026-06-09 | 17,830 | 18,830 | 🔴 +5.61% | +0.34%p | ×0.8 | 🟢 외인 | +19.0억 | +17.5 | +1.5 | +0.1 | -19.1 | +0.0 | |
| 2026-06-08 | 19,600 | 17,830 | 🔵 -9.03% | +0.66%p | ×1.4 | 🟢 외인 | +45.9억 | +46.6 | -0.7 | +0.4 | -46.8 | +0.5 | |
| 2026-06-05 | 19,810 | 19,600 | 🔵 -1.06% | -0.50%p | ×0.6 | 🔻 개인 | -0.7억 | -0.7 | +0.0 | +0.2 | +0.4 | +0.1 | |
| 2026-06-04 | 20,250 | 19,810 | 🔵 -2.17% | -1.92%p | ×0.6 | 🟢 외인 | +1.6억 | +1.9 | -0.3 | -0.3 | -1.3 | +0.1 | |
| 2026-06-02 | 21,100 | 20,250 | 🔵 -4.03% | -0.24%p | ×0.9 | 🟢 외인 | +19.6억 | +19.6 | +0.0 | -0.7 | -14.1 | -4.9 | |
| 2026-06-01 | 21,450 | 21,100 | 🔵 -1.63% | +0.00%p | ×1.8 | 🔻 개인 | -29.9억 | -29.7 | -0.2 | +0.7 | +29.3 | -0.1 | |
| 2026-05-29 | 21,600 | 21,450 | 🔵 -0.69% | +0.47%p | ×1.4 | 🟢 외인 | +0.4억 | +36.3 | -35.9 | -0.4 | +0.5 | -0.5 | |
| 2026-05-28 | 22,400 | 21,600 | 🔵 -3.57% | -0.89%p | ×0.5 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | -0.6 | +0.2 | -0.5 | |
| 2026-05-27 | 22,500 | 22,400 | 🔵 -0.44% | +2.23%p | ×0.8 | 🔻 개인 | +0.6억 | +0.6 | +0.0 | +0.0 | +3.1 | -3.7 | |
| 2026-05-26 | 23,250 | 22,500 | 🔵 -3.23% | +0.86%p | ×0.7 | 🔻 개인 | -17.3억 | -18.0 | +0.8 | +0.1 | +17.0 | +0.2 | |
| 2026-05-22 | 21,300 | 23,250 | 🔴 +9.15% | +0.93%p | ×0.9 | 🟢 외인 | +5.9억 | +6.5 | -0.6 | +0.7 | -10.0 | +3.4 |
일자별 사유 (최신 위)
2026-06-29
- 사유: —
- 섹터 컨텍스트: KOSPI:제약 (smart +895억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)